ALBT: Avalon GloboCare Corp. - Summary | Jitta

Avalon GloboCare Corp.

NASDAQ:ALBT

Price
$0.28
Loss Chance
57.9%
1.81JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
3,563 / 4,210
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (41)
Recent Business Performance (36)
Financial Strength (33)
Return to Shareholders (13)
Competitive Advantage (41)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 60 days
Revenue and EarningRevenue loss detected in 2024
Operating MarginDeclined
New Share IssuedMore than 50% in 5 years
CapExVery High
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
1.81
100.00%
3.43
746.25%
Real Estate Operating Companies
2.04
> 1,000%
2.04
100.00%
3.80
> 1,000%
COMPANY DESCRIPTION
Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.